Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal...

Area of Science:

• Cardiology
• Electrophysiology
• Cardiac Pathophysiology

Background:

• The left atrium (LA) is crucial for cardiovascular homeostasis, performing reservoir, conduit, systolic, and neurohormonal functions.
• Atrial fibrillation (AF) often reflects underlying LA disease, especially in heart failure patients, leading to LA remodeling, impaired contractility, and neurohormonal dysregulation.
• Catheter ablation, while intended to treat AF, can cause myocardial injury, cardiomyocyte loss, and fibrosis, further compromising LA function.

Purpose of the Study:

• To investigate the impact of catheter ablation on left atrial (LA) function in patients with pre-existing LA disease and fibrosis.
• To evaluate the efficacy and safety of catheter ablation in patients with long-standing AF, LA fibrosis, and comorbidities like obesity, diabetes, or heart failure with preserved ejection fraction.
• To identify patient subgroups where catheter ablation may be suboptimal or even detrimental.

Main Methods:

• Review of existing literature on left atrial remodeling, fibrosis, and the effects of catheter ablation in cardiovascular disease.
• Analysis of pathophysiological changes in the LA following catheter ablation, including myocardial injury, fibrosis, and functional impairment.
• Clinical assessment of outcomes in patients undergoing catheter ablation for AF, with a focus on those with pre-existing LA fibrosis and comorbidities.

Main Results:

• Catheter ablation can induce further LA injury and fibrosis, potentially worsening LA stiffness and impairing transport functions.
• Patients with long-standing AF, significant LA fibrosis, and conditions like obesity or heart failure are prone to suboptimal outcomes post-ablation.
• The fibrotic LA, while a substrate for AF, may represent a poor substrate for successful catheter ablation, leading to high recurrence rates and potential hemodynamic compromise.

Conclusions:

• Catheter ablation may not be beneficial and could be detrimental in patients with a fibrotic left atrium, especially those with heart failure and other comorbidities.
• These patients may experience worsened hemodynamic status and clinical outcomes, with a lower likelihood of long-term sinus rhythm restoration.
• Further research is essential to understand the risks and benefits of catheter ablation in this vulnerable patient population and to explore alternative therapeutic strategies.